H. Ganeshan

发表

A Small Peptide (CEL-1000) Derived from the β-Chain of the Human Major Histocompatibility Complex Class II Molecule Induces Complete Protection against Malaria in an Antigen-Independent Manner

Denise L. Doolan, Daniel J. Carucci, D. Carucci, 2004, Antimicrobial Agents and Chemotherapy.

Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana.

L. Amoah, M. Sedegah, H. Ganeshan, 2021, Vaccine.

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

S. Hoffman, D. Carucci, Joe D. Cohen, 2004, Vaccine.

Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component

D. Carucci, D. Doolan, J. Bruder, 2011, PloS one.

Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein

Bjoern Peters, A. Sette, Yohan Kim, 2010, Malaria Journal.

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity

S. Hoffman, D. Carucci, D. Freilich, 2016, Malaria Journal.

Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization

D. Carucci, M. Galinski, D. Kaslow, 2007, Malaria Journal.

Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes

Bjoern Peters, M. Sedegah, H. Ganeshan, 2016, PloS one.

IMRAS—Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS

T. Richie, M. Sedegah, H. Ganeshan, 2021, PloS one.

IMRAS—A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents

S. Chaudhury, T. Richie, L. Garver, 2020, PloS one.

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming

M. Sedegah, E. Abot, H. Ganeshan, 2015, Human vaccines & immunotherapeutics.

Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes

Bjoern Peters, A. Sette, Yohan Kim, 2014, PloS one.

Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection

C. Broder, S. Pollett, T. Burgess, 2022, PloS one.

Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1

Bjoern Peters, S. Buus, Yohan Kim, 2013, Malaria Journal.

Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults

M. Sedegah, H. Ganeshan, K. Kusi, 2015, Malaria Journal.

A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults

S. Chaudhury, A. Lawrie, E. Bergmann-Leitner, 2021, PloS one.

Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.

Sumana Chakravarty, Joana C. Silva, S. Hoffman, 2017, JCI insight.

I dentiftcation of minhng , l human MllC-restricted

M. Sedegah, H. Ganeshan, Jun Huang, 2017 .

Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection

Edward B. Miller, J. Bruder, T. Richie, 2013, Human vaccines & immunotherapeutics.

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

D. Carucci, Awalludin Sutamihardja, A. J. McCoy, 2013, PloS one.

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

S. Hoffman, D. Freilich, J. Aguiar, 2012, Human vaccines & immunotherapeutics.

Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults

D. Carucci, D. Doolan, J. Bruder, 2011, PloS one.

A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP142 in a Prime/Boost Heterologous Immunization Regimen Partially Protects Aotus Monkeys against Blood-Stage Challenge

D. Tang, D. Doolan, T. Richie, 2017, Clinical and Vaccine Immunology.

Comparison of the impact of allelic polymorphisms in PfAMA1 on the induction of T Cell responses in high and low malaria endemic communities in Ghana

B. Peters, M. Sedegah, H. Ganeshan, 2021, Malaria journal.

CHARM: COVID-19 Health Action Response for Marines–Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test

S. Sealfon, D. Weir, S. Lizewski, 2022, PloS one.

CHARM: COVID-19 Health Action Response for Marines – association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test

S. Sealfon, D. Weir, S. Lizewski, 2021, bioRxiv.

Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes

Bjoern Peters, M. Sedegah, H. Ganeshan, 2016, PloS one.

Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria.

Bjoern Peters, L. Amoah, M. Sedegah, 2023, Vaccine.

Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population

Bjoern Peters, Yohan Kim, L. Amoah, 2020, PloS one.

Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria

Bjoern Peters, Yohan Kim, M. Sedegah, 2016, Malaria Journal.

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

Bjoern Peters, A. Sette, Yohan Kim, 2013, Malaria Journal.

Comparative analysis of the ex vivo IFN-gamma responses to CD8+ T cell epitopes within allelic forms of PfAMA1 in subjects with natural exposure to malaria

B. Peters, M. Sedegah, H. Ganeshan, 2021, PloS one.

Bjoern Peters, S. Buus, Yohan Kim, 2013, Malaria Journal.

Reduced immunogenicity of DNA vaccine plasmids in mixtures

M. Sedegah, Y. Charoenvit, H. Ganeshan, 2004, Gene Therapy.

Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine

M. Sedegah, H. Ganeshan, Jun Huang, 2023, Frontiers in Immunology.